HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A comparison of the conjugation of DNTB and other dinitrobenzenes with free protein radicals and their ability to sensitize or tolerize.

Abstract
Of several dinitrobenzenes tested, 2,4-dinitrothiocyanatebenzene (DNTB) was found to be the only one that did not induce contact sensitivity when applied to the guinea pig ear epicutaneously, but when applied epicutaneously it induced tolerance to 2,4-dinitrofluorobenzene (DNFB). The manner in which DNFB, DNTB, and other dinitrobenzene compounds conjugated in vitro to soluble proteins, at physiologic pH, was examined. By measuring the free amino and sulfydryl radicals in the protein before and after conjugation, it was possible to determine to which groups the hapten was bound. It was found that although all the haptens bound to the free sulfydryl groups, DNTB was the only one that did not bind to amino groups. It is suggested that to be an epicutaenous tolerizer, as opposed to sensitizer, a hapten should bind to sulfydryl groups exclusively. It is hoped that a search for agents binding in a similar manner will reveal epicutaneous tolerizers for important industrial sensitizers.
AuthorsD Parker, P V Long, J L Turk
JournalThe Journal of investigative dermatology (J Invest Dermatol) Vol. 81 Issue 3 Pg. 198-201 (Sep 1983) ISSN: 0022-202X [Print] United States
PMID6886470 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Dinitrobenzenes
  • Free Radicals
  • Nitrobenzenes
  • Proteins
  • Dinitrofluorobenzene
  • 2,4-dinitrothiocyanatobenzene
Topics
  • Animals
  • Dermatitis, Contact
  • Dinitrobenzenes (metabolism)
  • Dinitrofluorobenzene (metabolism)
  • Female
  • Free Radicals
  • Guinea Pigs
  • Male
  • Nitrobenzenes (metabolism)
  • Proteins (metabolism)
  • Skin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: